CAPITAL FUND MANAGEMENT S.A.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1323645
PARIS, I0
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,311,542
-$19,583,406 QoQ
Shares Held
71,088
-42.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#201
of 1,742 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$5,348,420
PutShares
11,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. VRTX ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
155,904 | $46,931,781 | |
| 2 | INCY |
Incyte Corp
|
336,318 | $38,125,008 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
71,088 | $35,311,542 | |
| 4 | EXEL |
Exelixis, Inc.
|
527,235 | $28,686,856 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
329,554 | $26,130,336 | |
| 6 | MRNA |
Moderna, Inc.
|
277,758 | $19,451,392 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
184,231 | $16,018,885 | |
| 8 | INSM |
INSMED Inc
|
148,976 | $15,883,821 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,311,542 | 71,088 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $54,894,948 | 122,934 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $5,348,420 | 11,500 | Put | Sole | 2024-11-13 | |
| 2024-03-31 | $25,720,155 | 61,530 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $5,643,135 | 13,500 | Put | Sole | 2024-05-15 | |
| 2023-09-30 | $6,085,450 | 17,500 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $14,361,662 | 41,300 | Put | Sole | 2023-11-14 | |
| 2022-12-31 | $4,245,066 | 14,700 | Call | Sole | 2023-02-13 | |
| 2022-09-30 | $6,630,466 | 22,900 | Call | Sole | 2022-11-14 | |
| 2021-03-31 | $3,777,121 | 17,577 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $12,872,258 | 54,465 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $18,535,725 | 68,116 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,612,563 | 19,333 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,546,675 | 6,500 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $2,784,015 | 11,700 | Call | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||